Medicare Enrolled
Dr. Amanda Ribbeck, M.D.
Interventional Cardiology · Amherst, NY
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ribbeck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ribbeck?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ribbeck
Dr. Amanda Ribbeck is an interventional cardiology specialist in Amherst, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Ribbeck performed 3,632 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ribbeck received a total of $6,535 from 42 pharmaceutical and/or device companies across 356 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ribbeck is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 12% volume in NY
$6,535 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,632
Medicare services
Top 12% in NY for interventional cardiology
Not available
Unique patients (not deduplicated)
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
780 | $43 | $80 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
516 | $10 | $50 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
439 | $94 | $147 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
346 | $84 | $230 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
259 | $131 | $580 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
243 | $46 | $250 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
216 | $320 | $897 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
117 | $50 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
103 | $112 | $241 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
88 | $18 | $76 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $57 | $162 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
61 | $20 | $75 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
58 | $17 | $50 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
48 | $47 | $300 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
42 | $163 | $480 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
39 | $7 | $22 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
37 | $23 | $110 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
35 | $39 | $180 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
35 | $18 | $140 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
29 | $69 | $195 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
15 | $185 | $378 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
15 | $16 | $45 |
| SPECT nuclear medicine scan, 1 area A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body. |
13 | $268 | $500 |
| Technetium Tc-99m pyrophosphate diagnostic injection A diagnostic injection of Technetium Tc-99m pyrophosphate used for imaging studies. The dose administered is up to 25 millicuries. |
13 | $21 | $63 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
10.8% high complexity
50.9% medium
38.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,535
Total received (2018-2024)
Avg $934/year across 7 years
Top 48% in NY for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
356
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,696
2023
$1,618
2022
$1,227
2021
$936
2020
$391
2019
$442
2018
$225
Payments by company (2024)
Kiniksa Pharmaceuticals International, plc
$164
AstraZeneca Pharmaceuticals LP
$137
Novartis Pharmaceuticals Corporation
$135
E.R. Squibb & Sons, L.L.C.
$104
Abbott Laboratories
$96
Alnylam Pharmaceuticals Inc.
$92
Edwards Lifesciences Corporation
$89
SCPHARMACEUTICALS INC.
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$73
Medtronic, Inc.
$72
Amgen Inc.
$63
Boston Scientific Corporation
$56
CVRx, Inc.
$52
ABIOMED
$47
Regeneron Healthcare Solutions, Inc.
$46
Lexicon Pharmaceuticals, Inc.
$40
Novo Nordisk Inc
$39
BIOTRONIK INC.
$31
Impulse Dynamics (USA) Inc.
$30
Daiichi Sankyo Inc.
$29
SANOFI-AVENTIS U.S. LLC
$28
Recor Medical Inc
$25
Merck Sharp & Dohme LLC
$24
Inspire Medical Systems, Inc.
$24
HEARTFLOW, INC.
$22
Actelion Pharmaceuticals US, Inc.
$20
Top 3 companies account for 25.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$483
E.R. Squibb & Sons, L.L.C.
$460
Boehringer Ingelheim Pharmaceuticals, Inc.
$412
Amgen Inc.
$381
AstraZeneca Pharmaceuticals LP
$347
BIOTRONIK INC.
$314
Janssen Pharmaceuticals, Inc
$306
Edwards Lifesciences Corporation
$279
Astellas Pharma US Inc
$262
SANOFI-AVENTIS U.S. LLC
$225
PFIZER INC.
$223
Abbott Laboratories
$219
Amarin Pharma Inc.
$217
Alnylam Pharmaceuticals Inc.
$212
Regeneron Healthcare Solutions, Inc.
$182
Boston Scientific Corporation
$182
Kiniksa Pharmaceuticals International, plc
$164
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$161
Esperion Therapeutics, Inc.
$152
Merck Sharp & Dohme LLC
$139
Kiniksa Pharmaceuticals, Ltd.
$134
Novo Nordisk Inc
$129
Kestra Medical Technology Services, Inc.
$116
Impulse Dynamics (USA) Inc.
$105
SCPHARMACEUTICALS INC.
$96
Medtronic, Inc.
$88
Lexicon Pharmaceuticals, Inc.
$75
iRhythm Technologies, Inc.
$61
Baxter Healthcare
$58
Daiichi Sankyo Inc.
$53
CVRx, Inc.
$52
ABIOMED
$47
Gilead Sciences, Inc.
$28
Recor Medical Inc
$25
Inspire Medical Systems, Inc.
$24
Tactile Systems Technology Inc
$24
Merck Sharp & Dohme Corporation
$23
HEARTFLOW, INC.
$22
Actelion Pharmaceuticals US, Inc.
$20
Lundbeck LLC
$15
BOSTON SCIENTIFIC CORPORATION
$13
Medtronic Vascular, Inc.
$11
Top 3 companies account for 20.7% of all-time payments
Associated products mentioned in payments ›
AMPLATZER AMULET · AVEIR · Acticor 7 VR-T DX · Arcalyst · Assure WCD · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · Confirm Rx · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVKEEZA · Edora 8 DR-T · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FUROSCIX · Flexitouch Plus · GALLANT · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · INSPIRE · Impella · Inpefa · JARDIANCE · JOT DX · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LOOP · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MITRACLIP · MULTAQ · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · Quartet CRT Lead · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · SYMPLICITY G3 · Saxenda · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN FLX · Wegovy · XARELTO · ZIO XT Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Interventional cardiologists in nearby ZIP areas
7
County median income
$71,175
Nearest hospital to ZIP centroid (approximate)
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
5.6 mi
5.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ribbeck is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 12% in NY).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ribbeck experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Ribbeck performed 780 regadenoson injection (lexiscan) for heart stress test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ribbeck receive payments from pharmaceutical companies?
Yes. Dr. Ribbeck received a total of $6,535 from 42 companies across 356 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ribbeck's costs compare to other interventional cardiologists in Amherst?
Dr. Ribbeck's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ribbeck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Amherst
Browse interventional cardiologists in Amherst ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in NY
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in NY
Which NY interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology